Search by Drug Name or NDC

NDC 69238-1702-03 deferasirox 90 mg/1 Details

deferasirox 90 mg/1

deferasirox is a ORAL GRANULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is DEFERASIROX.

MedlinePlus Drug Summary

Deferasirox is used to treat adults and children 2 years of age and older who have too much iron in their body because they received many blood transfusions. It is also used to treat adults and children 10 years of age and older who have too much iron in their body because of a genetic blood disorder called non–transfusion-dependent thalassemia (NTDT). Deferasirox is in a class of medications called iron chelators. It works by attaching to iron in the body so that it can be excreted (removed from the body) in feces.

Related Packages: 69238-1702-03
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Deferasirox

Product Information

NDC	69238-1702
Product ID	69238-1702_cd673946-3321-416a-9ea1-06b8a23f1329
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	deferasirox
Proprietary Name Suffix	n/a
Non-Proprietary Name	deferasirox
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	GRANULE
Route	ORAL
Active Ingredient Strength	90
Active Ingredient Units	mg/1
Substance Name	DEFERASIROX
Labeler Name	Amneal Pharmaceuticals NY LLC
Pharmaceutical Class	Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA214194
Listing Certified Through	2024-12-31

Package

NDC 69238-1702-03 (69238170203)

Pricing Information	N/A
NDC Package Code	69238-1702-3
Billing NDC	69238170203
Package	30 PACKET in 1 CARTON (69238-1702-3) / 1 GRANULE in 1 PACKET (69238-1702-1)
Marketing Start Date	2021-08-04
NDC Exclude Flag	N